Crossmark

ESM1 suppresses LncRNA GAS5/miR-23a-3p/PTEN axis to promote the cisplatin-chemotherapy resistance of ovarian cancer cells via activating the PI3K/AKT pathway

Crossref DOI link: https://doi.org/10.1007/s12672-025-02113-1

Published Online: 2025-03-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Hui

Fan, Tingyu

Qin, Mei

Chen, Shuanghua

Zhou, Wenchao

Wu, Peiting

Yuan, Yuwei

Tang, Xing

Zeng, Tian

Fang, Jiawen

Yi, Ting

Zhang, Juan

Zou, Juan

Li, Yukun
Funding

Funding for this research was provided by:

the Natural Science Foundation of China (82303246)

the Natural Science Foundation of HuNan Province (2023JJ41066)
License Information

Text and Data Mining valid from 2025-03-16

Version of Record valid from 2025-03-16
More Information

Article History

Received: 1 December 2024

Accepted: 10 March 2025

First Online: 16 March 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below